Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01530919 · ClinicalTrials.gov registry record

Minimally Invasive Radioguided Parathyroidectomy

A clinical trial of Primary Hyperparathyroidism, sponsored by University of Louisville.

Completed
Registry status
856
Enrollment target
1
Study location

NCT01530919 is a study of Primary Hyperparathyroidism that has completed, run by University of Louisville. The registered enrollment target is 856 participants, above the 630-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (36% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01530919, a study of Primary Hyperparathyroidism, has completed, sponsored by University of Louisville.

COMPLETED
Registry status
856 participants
Enrollment target
1
Study location

Study Summary

The main purpose of this research study is to evaluate the effectiveness of a minimally invasive surgical approach to removing parathyroid gland(s). The researchers are also interested in analyzing abnormal parathyroid tissue for changes in genes and proteins that may contribute to overactive parathyroid gland(s).

Interventions

  • PROCEDURE Minimally invasive radioguided parathyroidectomy

Study Locations (1)

Kentucky

  • University of Louisville - Louisville

Trial Details

FieldValue
Enrollment Target 856 participants
Start Date 1998-09
Est. Completion 2017-04

Sponsor

University of Louisville

217 total trials

What the Registry Record Tells You About NCT01530919

The ClinicalTrials.gov registry entry for NCT01530919 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 856 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 630-participant average among 7 other Primary Hyperparathyroidism trials with a reported enrollment target (36% higher). The listed sponsor is University of Louisville, which has 217 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Primary Hyperparathyroidism appearing as the primary indexed condition, and to 1 intervention - of which Minimally invasive radioguided parathyroidectomy is the first listed.

NCT01530919 reports 1 study location spanning 1 distinct geographic area - top geographies include Kentucky.

Frequently Asked Questions

What is clinical trial NCT01530919 about?

NCT01530919 is a clinical study titled "Minimally Invasive Radioguided Parathyroidectomy". The main purpose of this research study is to evaluate the effectiveness of a minimally invasive surgical approach to removing parathyroid gland(s). The researchers are also interested in analyzing abnormal parathyroid tissue for changes in genes and proteins that may contribute to overactive parath...

What is the current status of trial NCT01530919?

This trial is currently completed. The enrollment target is 856 participants. The study started on 1998-09. Estimated completion is 2017-04.

What conditions does trial NCT01530919 study?

This clinical trial studies the following conditions: Primary Hyperparathyroidism.

What interventions are being tested in trial NCT01530919?

The interventions under investigation include: Minimally invasive radioguided parathyroidectomy (PROCEDURE).

Who is sponsoring clinical trial NCT01530919?

This trial is sponsored by University of Louisville, which has 217 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01530919 being conducted?

This trial has 1 study location across Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Primary Hyperparathyroidism

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.